139 related articles for article (PubMed ID: 32450313)
1. Meta-Analysis with Trial Sequential Analysis on the Efficacy and Safety of Erythropoietin in Traumatic Brain Injury: A New Paradigm.
Katiyar V; Chaturvedi A; Sharma R; Gurjar HK; Goda R; Singla R; Ganeshkumar A
World Neurosurg; 2020 Oct; 142():465-475. PubMed ID: 32450313
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of erythropoietin for traumatic brain injury.
Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
[TBL] [Abstract][Full Text] [Related]
4. Potential Efficacy of Erythropoietin on Reducing the Risk of Mortality in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Liu C; Huang C; Xie J; Li H; Hong M; Chen X; Wang J; Wang J; Li Z; Wang J; Wang W
Biomed Res Int; 2020; 2020():7563868. PubMed ID: 33178833
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of erythropoietin in patients with traumatic brain injury: A systematic review and meta-analysis.
Lee J; Cho Y; Choi KS; Kim W; Jang BH; Shin H; Ahn C; Lim TH; Yi HJ
Am J Emerg Med; 2019 Jun; 37(6):1101-1107. PubMed ID: 30220640
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
7. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
8. Does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled-analysis.
Li Y; Zhang J; Wang H; Zhu L; Zhang H; Ma Q; Liu X; Dong L; Lu G
Neurol Sci; 2022 Jun; 43(6):3783-3793. PubMed ID: 35044560
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
[TBL] [Abstract][Full Text] [Related]
11. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
14. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety of multiple doses of erythropoietin for the treatment of traumatic brain injury: A systematic review and network meta-analysis.
Zheng Q; Duan D; Xu J; Wang X; Ge Y; Xiong L; Yang J; Wulayin S; Luo X
Front Neurol; 2022; 13():998320. PubMed ID: 36582613
[TBL] [Abstract][Full Text] [Related]
16. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
Razak A; Hussain A
J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.
Skrifvars MB; Moore E; Mårtensson J; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
Acta Anaesthesiol Scand; 2019 Feb; 63(2):200-207. PubMed ID: 30132785
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
[TBL] [Abstract][Full Text] [Related]
20. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]